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Background: Mice homozygous for the juvenile alopecia mutation (jal) display patches of hair loss that appear as
soon as hair develops in the neonatal period and persist throughout life. Although a report initially describing this
mouse variant suggested that jal maps to mouse Chromosome 13, our preliminary mapping analysis did not
support that claim.
Results: To map jal to a particular mouse chromosome, we produced a 103-member intraspecific backcross panel
that segregated for jal, and typed it for 93 PCR-scorable, microsatellite markers that are located throughout the
mouse genome. Only markers from the centromeric tip of Chromosome 2 failed to segregate independently from
jal, suggesting that jal resides in that region. To more precisely define jal’s location, we characterized a second,
374-member backcross panel for the inheritance of five microsatellite markers from proximal Chromosome 2. This
analysis restricted jal’s position between D2Mit359 and D2Mit80, an interval that includes Il2ra (for interleukin 2
receptor, alpha chain), a gene that is known to be associated with alopecia areata in humans. Complementation
testing with an engineered null allele of Il2ra, however, showed that jal is a mutation in a distinct gene. To further
refine the location of jal, the 374-member panel was typed for a set of four single-nucleotide markers located
between D2Mit359 and D2Mit80, identifying a 0.55 Mb interval where jal must lie. This span includes ten genes—
only one of which, Gata3 (for GATA binding protein 3)—is known to be expressed in skin. Complementation
testing between jal and a Gata3 null allele produced doubly heterozygous, phenotypically mutant offspring.
Conclusions: The results presented indicate that the jal mutation is a mutant allele of the Gata3 gene on mouse
Chromosome 2. We therefore recommend that the jal designation be changed to Gata3jal, and suggest that this
mouse variant may provide an animal model for at least some forms of focal alopecia that have their primary
defect in the hair follicle and lack an inflammatory component.
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The initial assignment of spontaneous hair variants to
particular genes can be a crucial first step in the long-
term investigation into the role these genes play in the
normal (and disrupted) development of the mammalian
integument (for example, see refs. [1-9]). Unfortunately,
several naturally-occurring hair and skin variants in mice* Correspondence: kingt@ccsu.edu
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reproduction in any medium, provided the orremain out-of-the-mainstream of modern biological in-
vestigation, simply because they have not yet been
assigned to a causative gene or even, in some cases, to a
particular chromosome. One such variant is generated
by the recessive juvenile alopecia mutation, abbreviated
jal. This variant arose on the standard C3H/HeJ genetic
background, and its origin and novel phenotype were
described in a single brief paper published by McElwee
et al. in 1999 [10]. Homozygous mice exhibit patchy hair
loss (see Figure 1), wavy truncal hair, defects in hair folli-
cles, and abnormalities in hair growth cycle regulation.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A three-month-old C3H/HeJ-jal/J mouse, homozygous
for jal.
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is evident as soon as hair develops in the neonatal
period. Although McElwee and coworkers suggested that
jal is located on mouse Chromosome (Chr) 13 [10], our
preliminary backcross analysis [11] clearly showed that
jal does not map anywhere on that chromosome.
Here, we describe the completed molecular-genetic
analysis of a pair of large backcross families that allowed
us to locate jal on mouse Chr 2, and then restrict its lo-
cation to a small, defined interval at the centromeric tip.
In addition, we describe complementation testing be-
tween jal and engineered null alleles of two co-localizing
candidate genes, one of which (Gata3, for GATA bind-
ing protein 3) we identify as the likely basis of the juven-
ile alopecia phenotype in mice.
Methods
Mice
Mice from the standard inbred strains C57BL/6 J, C3H/
HeJ, A/J, as well as inbred C3H/HeJ-jal/J mice were
obtained from The Jackson Laboratory (Bar Harbor, ME,
USA). Mice homozygous for the mutant jal allele were
most reliably identified by vibrissae defects that are
first evident shortly after birth. By two weeks of age,homozygotes present with distinct patches of hair loss
(most often on the dorsal surface) that persist through-
out life (see Figure 1). The amount of body surface af-
fected varies widely among homozygous individuals
(from less than 5% to greater than 95% [see Additional
file 1]), even within the inbred C3H/HeJ-jal strain.
While both male and female jal/jal homozygotes are
fertile, we have maintained the C3H/HeJ-jal line since
2009 by crossing heterozygous females with homozy-
gous males, to produce segregating litters.
Mice carrying a targeted mutation in the interleukin 2
receptor, alpha chain gene (Il2ratm1Dw) were also
obtained from The Jackson Laboratory. The creation of
the Il2ratm1Dw loss-of-function allele is described by
Willerford et al. [12]. In brief, these investigators used
homologous recombination to replace a 5.5 kb segment
of the Il2ra gene which contains Exons 2 and 3 and
encodes the interleukin 2 binding site [13] with a phos-
phoglycerate kinase (PGK)-neomycin resistance (neo)
cassette. Mice carrying a targeted mutation in the GATA
binding protein 3 gene (Gata3tm1Gsv) were kindly do-
nated by Dr. James Douglas Engel (University of Michigan,
Ann Arbor, MI, USA). The creation of the Gata3tm1Gsv
loss-of-function/reporter allele is described by van
Doorninck et al. [14]. In brief, these investigators replaced
157 bp in Exon 2, including the start codon, with a nuclear
localization signal (nls)-lacZ fusion cassette, followed by a
PGK-hygromycin resistance (hyg) cassette.
All studies were in compliance with protocols ap-
proved by the Institutional Care and Use Committee
(IACUC) at Central Connecticut State University (New
Britain, CT, USA).
DNA isolation and analysis
Genomic DNA was isolated from 3 mm tail tip biopsies
taken from two-week-old mice, using Nucleospin kits
from BD Biosciences (Palo Alto, CA, USA). The polymer-
ase chain reaction (PCR) was performed using the Titan-
ium PCR kit from Clontech (Palo Alto, CA, USA).
Oligonucleotide primers for PCR were synthesized by
Invitrogen (Carlsbad, CA, USA), based on sequence infor-
mation from online sources [15,16]. In addition to stand-
ard, PCR-scorable, microsatellite markers [17], we also
assayed 4 markers based on single-nucleotide polymor-
phisms that have been reported to differ between the A/J
and C3H/HeJ strains [15,16]. These markers, designated
herein as SNP1-4, are described in detail in Additional file
2 and Additional file 3. To distinguish between Il2ratm1Dw
carriers and wild type mice, we used the 4-primer PCR
assay recommended by the mouse supplier (The Jackson
Laboratory). Two of these primers (5′CTGTGTCTGTAT
GACCCACC 3′, and 5′ CAGGAGTTTCCTAAGCAACG
3′) correspond to Exon 2 of Il2ra, which in the mutant
has been replaced with a PGK-neo cassette, and yield a
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other two primers (5′ CTTGGGTGGAGAGGCTATTC
3′, and 5′AGGTGAGATGACAGGAGATC 3′) corres-
pond to the neo gene, and direct the amplification of a
280 bp amplimer from mutant DNA templates. To distin-
guish between Gata3tm1Gsv carriers and wild type mice, we
used a 3-primer PCR assay of our own design. For this
test, one primer-pair (forward primer, 5′ CCCTAAACC
CTCCTTTTTGC 3′, and reverse primer 5′ GATACCTC
TGCACCGTAGCC 3′) flanked the site of the engineered
disruption in Exon 2, and produced a 399 bp amplimer
with wild type templates; that forward primer and second
reverse primer (5′ GTTTTCCCAGTCACGACGTT 3′),
based on sequences within in lacZ, yielded a 320 bp
amplimer that is specific to the Gata3tm1Gsv allele.
PCR products plus 2 ul loading buffer (bromophenol
blue in 20% Tris-buffered sucrose) were electrophoresed
through 3.25% NuSeive 3:1 agarose gels (Lonza, Rockland,
ME, USA). Gels were stained with ethidium bromide
(0.5 ug/mL) and photographed under ultraviolet light.
For sequence analysis, about 1.5 ug of individual PCR
amplimers were concentrated into a 30 ul volume using
QIAquick PCR Purification kits (Qiagen, Valencia, CA,
USA). Purified amplimers were shipped to SeqWright,
Inc. (Houston, TX, USA) for primer-extension analysis.
mRNA analysis
Total RNA was isolated from skin and thymus samples
taken from 1-month-old mutant and wild type mice
mice using the Nucleospin® RNA L kit by Macherey-
Nagel (Easton, PA, USA). cDNA was generated using
the SMARTer™ RACE cDNA amplification kit (Clontech
Laboratories). To amplify Gata3-specific cDNA, primer
pairs that flanked exon junction boundaries were used in
“step-down” PCR reactions. The products of this initial
reaction were diluted 1:10 in Tricine-KOH buffer
(10 mM, pH 8.5) plus 1 mM EDTA, and were amplified
again in standard PCR reactions using the same or
nested primer pairs. Second-round amplimers were puri-
fied (as described above) and shipped to SeqWright,
Inc., for primer-extension sequencing.
Results
Mapping jal to a mouse chromosome
To determine if jal might be carried on the mouse X
chromosome, we conducted reciprocal crosses of homo-
zygous mutant mice with wild type mice from the
C57BL/6 J strain. Since the F1 progeny of both genders
were phenotypically wild type [see Additional file 4], we
confirm that the jal mutation is recessive, and conclude
that it must reside in an autosomal portion of the
genome.
To determine an autosomal location for the jal muta-
tion, we crossed (C57BL/6 J × C3H/HeJ-jal)F1 jal/+females back to their jal/jal sire. This cross produced 43
mutants and 60 wild type progeny, not significantly differ-
ent from the 1 mutant : 1 wild type ratio expected for a
testcross (χ2 = 2.81; P > 0.09). DNA samples isolated from
these 103 backcross (N2) progeny were analyzed for 93
PCR-scorable microsatellite markers from throughout the
mouse genome, including two from the pseudoautosomal
region on the X and Y chromosomes. The average spacing
of these markers was 16 cM, with the largest gap being a
31 cM interval on Chr 4. Among the markers tested, only
those from the centromeric portion of Chr 2 showed an
inheritance pattern significantly different from the 1 par-
ental : 1 recombinant ratio predicted if the marker and jal
were independently assorted (see Figure 2). The largest de-
viation (82 parental and 21 recombinant types; χ2 = 36.13;
P < 1.85 × 10-9) was observed for marker D2Mit1, which
is located 2.23 cM from the centromeric end of Chr 2 [15].
Meiotic fine-mapping
To more precisely locate jal on proximal Chr 2, we bred
(A/J × C3H/HeJ-jal/J)F1, jal/+ females back to C3H/
HeJ-jal/jal males, since this strain combination offered
more microsatellite and single nucleotide polymor-
phisms (SNPs) than the C57BL/6 J and C3H/HeJ strain
combination. These N2 mice were typed for jal and six
microsatellite markers on proximal Chr 2, as summa-
rized in Figure 3. The 374 progeny from this backcross
generation fit well with the expected 1 wild type : 1 mu-
tant ratio expected for a testcross (χ2 = 0.17; P > 0.67),
so mutants appear to be equally viable as their wild type,
heterozygous littermates. Segregation of markers among
this large N2 family indicates that jal is located between
D2Mit359 and D2Mit80, a span of about 11 cM that
contains some 11.66 Mb of DNA [16].
Complementation testing between jal and a targeted
mutation in Il2ra
A recent genome-wide association study for alopecia
areata (AA, OMIM #104000) in humans has implicated
several genes, including IL-2RA (for interleukin 2 recep-
tor, alpha chain) in the development of disfiguring hair
loss [18]. Because AA appears similar in at least some
ways to the mutant jal/jal phenotype in mice [10], and
because IL-2RA is located on human Chr 10p15.1—a re-
gion that is orthologous with the D2Mit359 and
D2Mit80 interval on Chr 2 in mouse—we decided to test
jal for complementation with the recessive Il2ratm1Dw
loss-of-function mouse mutation [12]. Because mice
homozygous for the targeted mutation show poor sur-
vival, we crossed Il2ratm1Dw/+ heterozygous females with
jal/jal males. If jal were a defect in Il2ra, then the mice
that inherit jal and Il2ratm1Dw could express no wild-
type gene product, and would therefore be expected to
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Figure 2 Inheritance of jal and 93 microsatellite markers, tested for goodness-of-fit with an independent-assortment model. Each
microsatellite marker tested is represented by a single bar positioned on the horizontal axis to show its approximate location in the mouse
genome. Markers from odd chromosomes are in black, those from even chromosomes are in blue. Results are plotted as negative log-
transformed P values calculated by the chi-squared method (with 1 degree of freedom). Bars descend below the baseline for those markers
where more recombinant types (i.e., jal inherited from the F1 mother together with a C57BL/6-derived marker allele, or jal
+ inherited with a
C3H/HeJ-derived marker) than parental types (jal inherited from the F1 mother together with a C3H/HeJ-derived marker allele, or jal
+ inherited
with a C57BL/6-derived marker) were observed in a set of 44 family members initially typed. Additional mice (up to all 103 in the backcross
panel) were typed for markers that showed a surplus of parental types such that goodness-of-fit testing with the expected 1:1 ratio gave P < 0.1.
Only markers from proximal Chr 2 showed a significant (above the orange line, where P < 0.05) or highly significant (above the red line, where
P < 0.01) excess of parental types, indicative of linkage with jal.
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perhaps as severe as the slower growth and progressive
wasting (cachexia) seen in mice homozygous for
Il2ratm1Dw [19]. Alternatively, if jal and Il2ra are distinct
genes, then all of the progeny would be phenotypically








= A/J-derived allele = C3H
Figure 3 Segregation of jal and five microsatellite markers on proxim
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mutants, the mutant jal allele must be located below D2Mit359, but above
wild type mice, the normal jal+ allele must be located below D2Mit359, buThis cross yielded 19 offspring that were typed by PCR
for the Il2ratm1Dw targeted disruption [Additional file 5]
and observed for 30 weeks. DNA typing identified 11
Il2ratm1Dw carriers (5 females and 6 males) and 8 mice
without the targeted disruption (7 females and 1 male),








al Chr 2 among 374 backcross mice. The five markers typed are
zygous F1 dam is depicted. Open boxes indicate A/J-derived alleles;
y a knob at the top of each haplotype. The number of progeny
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D2Mit80. The blue arrows similarly indicate that in these recombinant
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(Il2ratm1Dw carriers and noncarriers) displayed normal vi-
brissae and body hair. Furthermore, Il2ratm1Dw carriers
and noncarriers showed indistinguishable growth rates
(over a period of 30 weeks), with no signs of the cachexia
seen in Il2ratm1Dw/Il2ratm1Dw controls [Additional file 6].
These data suggest that jal is not an allele of Il2ra.Refinement of the meiotic map for jal
The 41 mice from the (A/J x C3H/HeJ-jal/J)F1 × C3H/
HeJ-jal/J backcross that were recombinant in the
D2Mit359 and D2Mit80 interval were next typed for
four, single-nucleotide polymorphisms designated SNP1,
SNP2, SNP3 and SNP4 (see Additional file 2 and
Additional file 3). This analysis identified six crossovers
between SNP1 and jal, and one crossover between jal
and SNP2, placing the jal mutation between these two
markers (see Figure 4a), a 0.55 Mb span that does not
include Il2ra. Of the ten genes or predicted genes [16]
that do map to this interval, only one—Gata3 (for














































Figure 4 Physical maps of the jal region on mouse Chr 2. (a) Molecula
Segregation data from the 374-member backcross panel shown in Figure 3
(shown in blue), an interval that also includes Il2ra (shown in gray). Single-n
file 3) were used to more precisely locate crossovers among the 41 mice re
the various pairs of adjacent markers are shown on the chromosome map,
jal between SNP1 and SNP2 (shown in red). The region between SNP1 and
scale bar shown), to show the locations of the 10 candidate genes (represe
only one, Gata3 (shown in yellow), is known to be expressed in skin. (b) Th
taller boxes are coding regions and shorter boxes are the 5′ or 3′ untransla
here so that the six exons are shown in ascending numerical order. The len
portions of exons shaded green have been sequenced in C3H/HeJ and C3Evaluation of Gata3 as the possible genetic basis of the
jal mutation
To determine if jal could be a mutant allele of the Gata3
gene, we imported a mouse carrying an engineered
Gata3 null allele, Gata3tm1Gsv [14], for complementation
testing. To create litters of half experimental (doubly
heterozygous) and half control offspring (carriers of the
jal allele, only), we crossed Gata3tm1Gsv/+ heterozygous
females with jal/jal males. If jal is the result of a defect
in Gata3, then the mice that inherit both jal and
Gata3tm1Gsv could express no wild-type gene product,
and would therefore be expected to show defective coats
and vibrissae. Alternatively, if jal and Gata3 are distinct
genes, then the dihybrid progeny (jal/+, Gata3tm1Gsv/+)
would be phenotypically normal.
This cross yielded 22 offspring that were typed by PCR
for the Gata3tm1Gsv targeted disruption. DNA typing
identified 11 Gatatm1Gsv carriers (6 females and 5 males)
and 11 mice without the disruption (10 females, 1 male),
as expected for a test cross (Figure 5a). All Gata3tm1Gsv
carriers displayed defective vibrissae and body hair (see
Figure 5c and e), while those without the targeted muta-


































r markers and genes on mouse Chr 2 that are linked with jal.
placed jal between microsatellite markers D2Mit359 and D2Mit80
ucleotide polymorphisms (SNP1-4, see Additional file 2 and Additional
combinant in this interval. The number of crossovers located between
which is drawn to the 5 Mb scale shown. Seven recombinants located
SNP2 is expanded below the chromosome map (drawn to the 0.1 MB
nted by orange boxes) that populate this span. Of these ten genes,
e Gata3 gene is expanded to show the arrangement of exons, where
ted regions. Gata3 is transcribed from the reverse strand, but is drawn
gth of each exon (in bp) is shown below the corresponding box. The
H/HeJ-jal/J DNA, but no differences were found.
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suggesting that these mutations are allelic.
All coding regions of the Gata3 gene, plus the 5′ un-
translated regions encoded by two alternative 1st exons
(see Figure 4b for transcript diagram and summary) were
sequenced in DNA isolated from C3H/HeJ and C3H/HeJ-
jal/J mice. However, we found no differences in DNA se-
quence between these coisogenic wild type and mutant
strains. In addition, using total RNA isolated from skin and
from thymus, we amplified (and sequenced) only
identically-spliced Gata3 cDNA from both wild type C3H/
HeJ and C3H/HeJ-jal/J mutant mice (see Additional file 7).
Discussion
The results presented suggest to us that the jal mutation

























Figure 5 The recessive jal and Gata3tm1Gsv mutations fail to complem
PCR test designed to identify Gata3tm1Gsv carriers. The 320 bp band and a f
specific to the mutant allele. The size standard shown (MM) is a 50 base pa
included pups displaying wild type (b) or mutant (c) hair development. All
phenotypically mutant pups all carried the targeted mutation. The snouts o
enlarged to show normal vs. defective vibrissae formation, respectively.We therefore recommend that the jal designation be
changed to Gata3jal. While we have not yet been able
to pinpoint a sequence-level change in Gata3jal, our
analysis has mostly been limited to coding regions.
We hypothesize that the Gata3jal defect is likely to
be a regulatory mutation (perhaps located in the
promoters, introns, or 3′ untranslated region) that—in
some fashion—impacts expression, processing, or degra-
dation of the Gata3jal transcript, although we find that
the Gata3-001 transcript appears to be normally
spliced. (We found no evidence for expression of the al-
ternative Gata3-201 transcript in total RNA isolated
from skin or thymus.) Quantitative and qualitative
evaluation of Gata3 transcripts or protein in the epider-
mis and hair follicles of C3H/HeJ-jal mice versus wild






ent in doubly heterozygous mice. (a) Typical results of a 3-primer
ainter, high-molecular-weight band (marked with an asterisk) are
ir ladder. A 10-day-old litter from a cross of Gata3tm1Gsv/Gata3+ x jal/jal
phenotypically wild type pups showed the 399 bp band only, and the
f one wild type (d) and one mutant (e) pup from the same litter are
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regulatory mutation) does seem consistent with the
variable phenotypic presentation of focal alopecia that
we observe in Gata3jal/Gata3jal mice (see Additional file 1).
Since at least some patches of normal fur are seen on most
if not all mutants (with some mutants showing almost
entirely normal coats), we anticipate that a standard
primary protein sequence (albeit improperly regulated) is
likely to be encoded by the Gata3jal allele.
The positional assignment of jal did not reveal (as
with our introductory examples, refs. 1–9) an unsus-
pected function of Gata3 in skin, since the study of
mouse strains engineered to carry targeted mutations
have previously indicated a role for Gata3 in hair follicle
development and skin cell lineage determination. Mice
homozygous for germline Gata3 null mutations die
around embryonic day 11 [22,23], precluding a detailed
assessment of the functional role of Gata3 in hair follicle
morphogenesis. However, some investigators have res-
cued mutant skin by transplantation to athymic hosts
[24], or else ablated Gata3 specifically in the epidermis
and hair follicles to reveal a crucial role in skin [25].
Since the mouse juvenile alopecia phenotype (patchy
hair loss) is distinct from that of these conditionally-
targeted mutants (complete baldness)—whatever its mo-
lecular basis—we believe that Gata3jal likely offers a
novel mutant allele, compared to the existing set of
engineered Gata3 disruptions. Addition of this viable
and phenotypically-unique natural variant to the Gata3
mutational inventory will surely allow new approaches
to the functional analysis of this locus, just as the recent
assignment of the spontaneous mouse frizzy (fr) and rat
“hairless” (frCR) mutations to the prostasin gene [26] has
productively advanced the in vivo analysis of Prss8 func-
tion in mammalian skin [27-29].
Haploinsufficiency of human GATA3 (due to loss-of-
function mutation of GATA3) causes a dominantly-
inherited syndrome of hypoparathyroidism, sensorineural
deafness, and renal disease (HDR, OMIM #146255) also
known as Barakat syndrome. Notably, HDR syndrome does
not appear to involve immune-related disorders or alopecia
[30,31]. The mouse Gata3tm1Gsv mutation has been shown
to generate deafness in heterozygotes [32-34], and is con-
sidered a model for HDR. It would certainly be interesting
to investigate parathyroid, cochlear, and renal function in
Gata3jal homozygotes and heterozygotes. In any case, a
molecular explanation for the distinct modes of inheritance
and phenotypic presentations of juvenile alopecia in mice
versus HDR in humans will require discovery of the precise
structure of the Gata3jal allele.
Histological observation of immune cell infiltrates as-
sociated with follicular dystrophy in AA [35,36] com-
bined with Petukhova et al.’s linkage of genes involved
in both innate and acquired immunity (including IL-2RA) to AA susceptibility [18] seem to firmly establish
AA as an autoimmune disorder. Although Gata3 is
known to play a crucial role in T cell development
[22,37], our elimination of Il2ra as the basis of the mu-
tant phenotype as well as McElwee et al.’s failure to de-
tect any signs of hair follicle inflammation in jal/jal
mutants [10] suggest that mouse juvenile alopecia does
not provide an ideal model for AA. However, it remains
possible that juvenile alopecia could provide an animal
model for at least some forms of focal alopecia which
may have their primary defect in the hair follicle and
lack an inflammatory component, but which may none-
theless be diagnosed as AA based on similar pathophysi-
ology (i.e., patchy hair loss). Indeed, the future study of
mouse juvenile alopecia may be helpful in identifying
such a homologous human condition, defining approaches
for distinguishing that disorder from AA, and in develop-
ing appropriate, specialized treatments.
Conclusions
The recessive jal mutation in mice maps to proximal
Chr 2, and has been shown by complementation testing
to be a variant allele of the Gata3 gene. While further
study will be needed to discover the molecular defect in
Gata3 that is the basis of the mutant phenotype, this
spontaneous mouse variant promises to provide an ani-
mal model for some forms of focal alopecia in humans
that have their primary defect in the hair follicle and
lack an inflammatory component.
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